A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the “Back of the Line” as a therapy for dyslipidemia?
| Image |  |
|---|---|
| Description | scientific article published on June 26, 2008 |
| Author/s |
author: Peter Paul Toth Kevin C. Maki |
| Publication date | June 26, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://api.elsevier.com/content/article/PII:S1933287408002729?httpAccept=text/xml |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |